Join the American Society of Gene & Cell Therapy (ASGCT) leading policymakers, industry executives, and scientific stakeholders to discuss the most pressing issues and collaborate on innovative solutions at this dynamic, 1.5-day event in Washington, D.C.
- Engage with Key Stakeholders: Hear directly from influential leaders from the FDA, and other federal agencies, as well as industry experts, on the policies that impact development and patient access.
- Navigate the Regulatory Landscape: Gain a deeper understanding of new regulatory policies, international harmonization efforts, and best practices for clinical development.
- Explore Innovative Payment Models: Discuss cutting-edge payment policies, including the CMMI CGT Access Model, and learn how to address the financial hurdles of high-value therapies.
Take advantage of this opportunity to meet leaders in the field, participate in dynamic sessions, and experience first-rate networking. This year's Policy Summit will be exclusively in-person.